IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 9409900 B1

PDFFull Text
Date of Patent:
Aug. 09, 2016

Filed:

Nov. 09, 2011

Compound for increasing kinase active and application thereof

Applicants:

Xinshan Kang, Beijing, CN;

Wei Long, Beijing, CN;

Cunbo MA, Beijing, CN;

Yanping Wang, Beijing, CN;

Xiaoyan Shen, Beijing, CN;

Yunyan HU, Beijing, CN;

Fenlai Tan, Beijing, CN;

Yinxiang Wang, Beijing, CN;

Inventors:

Xinshan Kang, Beijing, CN;

Wei Long, Beijing, CN;

Cunbo Ma, Beijing, CN;

Yanping Wang, Beijing, CN;

Xiaoyan Shen, Beijing, CN;

Yunyan Hu, Beijing, CN;

Fenlai Tan, Beijing, CN;

Yinxiang Wang, Beijing, CN;

Assignees:

FUJIAN HAIXI PHARMACEUTICALS, INC., Fuzhou, Fujian, CN;

BETTA PHARMACUETICALS CO., LTD., Hangzhou, Zhejiang, CN;

Other;

Attorney:

RatnerPrestia

Primary Examiner:

Jeffrey S Lundgren

Assistant Examiner:

Zenab Olabowale

Int. Cl.
CPC ...
C07D 417/12 (2006.01); C07D 233/88 (2006.01); C07D 405/14 (2006.01); C07D 417/14 (2006.01); C07D 213/74 (2006.01); C07D 213/80 (2006.01); C07D 213/803 (2006.01); C07D 241/20 (2006.01); C07D 277/42 (2006.01); C07D 285/08 (2006.01); C07D 401/12 (2006.01); C07D 403/12 (2006.01); C07D 405/04 (2006.01); C07D 405/12 (2006.01); C07D 401/14 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); C07D 213/74 (2013.01); C07D 213/80 (2013.01); C07D 213/803 (2013.01); C07D 233/88 (2013.01); C07D 241/20 (2013.01); C07D 277/42 (2013.01); C07D 285/08 (2013.01); C07D 401/12 (2013.01); C07D 401/14 (2013.01); C07D 403/12 (2013.01); C07D 405/04 (2013.01); C07D 405/12 (2013.01); C07D 405/14 (2013.01); C07D 417/12 (2013.01);
Abstract

The compound of Formula (I), pharmaceutically acceptable salts thereof, solvates thereof, chelates thereof, non-covalent complexes thereof or produgs of compounds mentioned above or the mixture of any form above mentioned are provided. The use of the compounds in manufacturing a medicament for the treatment and/or prevention of diabetes, obesity and related disorders.

Find Patent Forward Citations

Loading…